U.S. DHA Market Size, Share & Trends Analysis Report By Source, (Marine, Plant, Micro-algae), By Application (Pharmaceutical, Nutraceutical, Functional Food & Beverages), By Country, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within Immediate
U.S. DHA Market Size & Trends
The U.S. DHA market size was estimated at USD 352.11 million in 2024 and is projected tgrow at a CAGR of 5.2% from 2025 t2030. The market growth is primarily driven by increasing consumer awareness of the health benefits associated with omega-3 fatty acids. As more individuals recognize the importance of these nutrients for brain and heart health, the demand for DHA-rich products has surged. This trend is particularly evident in the dietary supplement sector, where consumers are actively seeking natural solutions tenhance their well-being.
The dietary supplement sector plays a crucial role in this demand as more individuals seek natural solutions tenhance their well-being. In addition, the incorporation of omega-3s intfunctional foods and beverages is expanding, catering thealth-conscious consumers looking for convenient options. Manufacturers are responding tthis trend by developing innovative products that meet the growing appetite for health-promoting ingredients.
Favorable government policies supporting dietary supplements are contributing tmarket growth. As consumers continue tprioritize health and wellness, the outlook for this market remains strong, with ongoing innovation and a shift towards sustainable sourcing further driving demand. Overall, the landscape is evolving, positioning omega-3s as a key component in the health and wellness sector.
U.S. DHA Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t2030. For this study, Grand View Research has segmented the U.S. DHA market report based on the source, & application:
U.S. DHA Market Size & Trends
The U.S. DHA market size was estimated at USD 352.11 million in 2024 and is projected tgrow at a CAGR of 5.2% from 2025 t2030. The market growth is primarily driven by increasing consumer awareness of the health benefits associated with omega-3 fatty acids. As more individuals recognize the importance of these nutrients for brain and heart health, the demand for DHA-rich products has surged. This trend is particularly evident in the dietary supplement sector, where consumers are actively seeking natural solutions tenhance their well-being.
The dietary supplement sector plays a crucial role in this demand as more individuals seek natural solutions tenhance their well-being. In addition, the incorporation of omega-3s intfunctional foods and beverages is expanding, catering thealth-conscious consumers looking for convenient options. Manufacturers are responding tthis trend by developing innovative products that meet the growing appetite for health-promoting ingredients.
Favorable government policies supporting dietary supplements are contributing tmarket growth. As consumers continue tprioritize health and wellness, the outlook for this market remains strong, with ongoing innovation and a shift towards sustainable sourcing further driving demand. Overall, the landscape is evolving, positioning omega-3s as a key component in the health and wellness sector.
U.S. DHA Market Report Segmentation
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t2030. For this study, Grand View Research has segmented the U.S. DHA market report based on the source, & application:
- Source Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
- Marine
- Plant
- Micro-algae
- Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
- Pharmaceutical
- Nutraceutical
- Functional Food & Beverages
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. U.S. DHA MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.2. Industry Value Chain Analysis
3.2.1. Raw Material Trends
3.2.2. Manufacturing/ Technology Trends
3.2.3. Sales Channel Analysis
3.2.4. Price Trend Analysis
3.2.4.1. Factors Influencing Prices
3.3. Regulatory Framework, By Regions
3.4. Supply Demand Analysis
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.2. Market Restraint Analysis
3.5.3. Industry Challenges
3.5.4. Industry Opportunities
3.6. Industry Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. Macro-environmental Analysis
CHAPTER 4. U.S. DHA MARKET: SOURCE ESTIMATES & TREND ANALYSIS
4.1. Source Movement Analysis & Market Share, 2023 & 2030
4.2. Marine
4.2.1. Marine U.S. DHA Market Estimates & Forecast, 2018 to 2030 (USD Million) (Kilotons)
4.3. Plant
4.3.1. Plant U.S. DHA Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
4.4. Mirco-Algae
4.4.1. Micro Algae U.S. DHA Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
CHAPTER 5. U.S. DHA MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Application Movement Analysis & Market Share, 2023 & 2030
5.2. Pharmaceutical
5.2.1. U.S. DHA Market Estimates & Forecast, in Pharmaceutical, 2018 to 2030 (USD Million) (Kilotons)
5.3. Nutraceutical
5.3.1. U.S. DHA Market Estimates & Forecast, in Nutraceutical, 2018 to 2030 (USD Million) (Kilotons)
5.4. Functional Food & Beverages
5.4.1. U.S. DHA Market Estimates & Forecast, in Functional Food & Beverages, 2018 to 2030 (USD Million) (Kilotons)
CHAPTER 6. U.S. DHA MARKET - COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Key Company Categorization
6.3. Company Market Share/Position Analysis, 2023
6.4. Company Heat Map Analysis
6.5. Vendor Landscape
6.5.1. List of Distributors
6.6. Strategy Mapping
6.7. Company Profiles
6.7.1. AK BIOPHARM CO.,LTD.
6.7.1.1. Participant’s overview
6.7.1.2. Financial performance
6.7.1.3. Product benchmarking
6.7.1.4. Recent developments
6.7.2. Bizen Chemical Co., Ltd.
6.7.2.1. Participant’s overview
6.7.2.2. Financial performance
6.7.2.3. Product benchmarking
6.7.2.4. Recent developments
6.7.3. Corbion
6.7.3.1. Participant’s overview
6.7.3.2. Financial performance
6.7.3.3. Product benchmarking
6.7.3.4. Recent developments
6.7.4. Croda International Plc
6.7.4.1. Participant’s overview
6.7.4.2. Financial performance
6.7.4.3. Product benchmarking
6.7.4.4. Recent developments
6.7.5. Epax
6.7.5.1. Participant’s overview
6.7.5.2. Financial performance
6.7.5.3. Product benchmarking
6.7.5.4. Recent developments
6.7.6. Glentham Life Sciences Limited
6.7.6.1. Participant’s overview
6.7.6.2. Financial performance
6.7.6.3. Product benchmarking
6.7.6.4. Recent developments
6.7.7. Haihang Industry
6.7.7.1. Participant’s overview
6.7.7.2. Financial performance
6.7.7.3. Product benchmarking
6.7.7.4. Recent developments
6.7.8. KD Pharma Group SA
6.7.8.1. Participant’s overview
6.7.8.2. Financial performance
6.7.8.3. Product benchmarking
6.7.8.4. Recent developments
6.7.9. LKT Laboratories
6.7.9.1. Participant’s overview
6.7.9.2. Financial performance
6.7.9.3. Product benchmarking
6.7.9.4. Recent developments
6.7.10. Nissui
6.7.10.1. Participant’s overview
6.7.10.2. Financial performance
6.7.10.3. Product benchmarking
6.7.10.4. Recent developments
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. U.S. DHA MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.2. Industry Value Chain Analysis
3.2.1. Raw Material Trends
3.2.2. Manufacturing/ Technology Trends
3.2.3. Sales Channel Analysis
3.2.4. Price Trend Analysis
3.2.4.1. Factors Influencing Prices
3.3. Regulatory Framework, By Regions
3.4. Supply Demand Analysis
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.2. Market Restraint Analysis
3.5.3. Industry Challenges
3.5.4. Industry Opportunities
3.6. Industry Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. Macro-environmental Analysis
CHAPTER 4. U.S. DHA MARKET: SOURCE ESTIMATES & TREND ANALYSIS
4.1. Source Movement Analysis & Market Share, 2023 & 2030
4.2. Marine
4.2.1. Marine U.S. DHA Market Estimates & Forecast, 2018 to 2030 (USD Million) (Kilotons)
4.3. Plant
4.3.1. Plant U.S. DHA Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
4.4. Mirco-Algae
4.4.1. Micro Algae U.S. DHA Estimates and Forecasts, 2018 - 2030 (USD Million) (Kilotons)
CHAPTER 5. U.S. DHA MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Application Movement Analysis & Market Share, 2023 & 2030
5.2. Pharmaceutical
5.2.1. U.S. DHA Market Estimates & Forecast, in Pharmaceutical, 2018 to 2030 (USD Million) (Kilotons)
5.3. Nutraceutical
5.3.1. U.S. DHA Market Estimates & Forecast, in Nutraceutical, 2018 to 2030 (USD Million) (Kilotons)
5.4. Functional Food & Beverages
5.4.1. U.S. DHA Market Estimates & Forecast, in Functional Food & Beverages, 2018 to 2030 (USD Million) (Kilotons)
CHAPTER 6. U.S. DHA MARKET - COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Key Company Categorization
6.3. Company Market Share/Position Analysis, 2023
6.4. Company Heat Map Analysis
6.5. Vendor Landscape
6.5.1. List of Distributors
6.6. Strategy Mapping
6.7. Company Profiles
6.7.1. AK BIOPHARM CO.,LTD.
6.7.1.1. Participant’s overview
6.7.1.2. Financial performance
6.7.1.3. Product benchmarking
6.7.1.4. Recent developments
6.7.2. Bizen Chemical Co., Ltd.
6.7.2.1. Participant’s overview
6.7.2.2. Financial performance
6.7.2.3. Product benchmarking
6.7.2.4. Recent developments
6.7.3. Corbion
6.7.3.1. Participant’s overview
6.7.3.2. Financial performance
6.7.3.3. Product benchmarking
6.7.3.4. Recent developments
6.7.4. Croda International Plc
6.7.4.1. Participant’s overview
6.7.4.2. Financial performance
6.7.4.3. Product benchmarking
6.7.4.4. Recent developments
6.7.5. Epax
6.7.5.1. Participant’s overview
6.7.5.2. Financial performance
6.7.5.3. Product benchmarking
6.7.5.4. Recent developments
6.7.6. Glentham Life Sciences Limited
6.7.6.1. Participant’s overview
6.7.6.2. Financial performance
6.7.6.3. Product benchmarking
6.7.6.4. Recent developments
6.7.7. Haihang Industry
6.7.7.1. Participant’s overview
6.7.7.2. Financial performance
6.7.7.3. Product benchmarking
6.7.7.4. Recent developments
6.7.8. KD Pharma Group SA
6.7.8.1. Participant’s overview
6.7.8.2. Financial performance
6.7.8.3. Product benchmarking
6.7.8.4. Recent developments
6.7.9. LKT Laboratories
6.7.9.1. Participant’s overview
6.7.9.2. Financial performance
6.7.9.3. Product benchmarking
6.7.9.4. Recent developments
6.7.10. Nissui
6.7.10.1. Participant’s overview
6.7.10.2. Financial performance
6.7.10.3. Product benchmarking
6.7.10.4. Recent developments
